Compliance of Long-term Home Non-invasive Ventilation for Patients With Chronic Obstructive Pulmonary Disease
Assessment of the Home Non-invasive Compliance in Patients With Chronic Obstructive Pulmonary Disease Following the Introduction of Long-term Ventilation. An Observational Study
Sponsor: France Oxygène
Listed as NCT04333901, this observational or N/A phase trial focuses on Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by France Oxygène, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2022 — Apr 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Jul 2022 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
May 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Dec 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- France Oxygène
- MBar
- Slb Pharma
- Vivisol
For direct contact, visit the study record on ClinicalTrials.gov .